ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $312,000 | -23.3% | 7,659 | +15.9% | 0.00% | 0.0% |
| Q4 2019 | $407,000 | -18.1% | 6,610 | -3.1% | 0.00% | -50.0% |
| Q3 2019 | $497,000 | -13.9% | 6,821 | -2.8% | 0.00% | 0.0% |
| Q2 2019 | $577,000 | +28.5% | 7,020 | +10.4% | 0.00% | 0.0% |
| Q1 2019 | $449,000 | +55.9% | 6,356 | -0.8% | 0.00% | +100.0% |
| Q4 2018 | $288,000 | -5.9% | 6,407 | +18.5% | 0.00% | 0.0% |
| Q3 2018 | $306,000 | -20.9% | 5,407 | -6.8% | 0.00% | -50.0% |
| Q2 2018 | $387,000 | +39.2% | 5,799 | +21.3% | 0.00% | +100.0% |
| Q1 2018 | $278,000 | +11.6% | 4,780 | +23.6% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | +22.7% | 3,866 | +15.4% | 0.00% | -50.0% |
| Q4 2016 | $203,000 | -0.5% | 3,349 | +9.1% | 0.00% | +100.0% |
| Q3 2016 | $204,000 | – | 3,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |